As per GOI Notification No. 03/2022 - Central Tax (Rate), GST of 5% is applicable* on all room charges exceeding Rs. 5000 per day (with the exception of ICU), for receiving treatment within our hospitals. (*On all discharges starting 18th July, 2022)

Media Room

Pioneering Cancer Registry data from Fortis Healthcare reveals key findings

Date : January 31, 2017

Cancer is a major cause for death and disease in India. According to The Indian Council of Medical Research (ICMR), there will be 17.3 lakh new cases of cancer, with breast, cervix and lung cancers being the most prominent, by the year 2020. The ICMR launched the National Cancer Registry Program (NCRP) to establish an age-wise gender based demographic profile of cancer patients. However challenges exist in the availability of updated data and figures for the public as well as key stakeholders.

To address this concern, Fortis Memorial Research Institute (FMRI) instituted a registry in 2013 and is the one of the few private institutions in India which provides reliable data on the prevalence and trends in cancer in India. The objective is to help concerned authorities to make vital decisions to combat this deadly disease. There is a pre-devised questionnaire which records information on socio demographic, diagnosis, clinical extent of the disease, stage, treatment, prognosis of the disease etc. as recorded in the case records by the clinicians. The data is checked and validated using quality control programmes /tools followed by cancer registries of the International Agency for Research on Cancer (IARC).

As per the FMRI Cancer Registry, the key findings for 2014 from across India are:

  • Out of 15,664 hospital visits of cancer entries reported in 2014, about 2,157 (13.8%) were new cancer cases with 1,191 (55.2%) of these being males and women accounting for 966 (44.8%) cases. The median age at diagnosis of cancer was 54.0 years in males and 52.4 years in females.
  • The highest number of cancer cases recorded from Indian states were from Haryana at 39.6 % followed by Delhi at 27.3 % and Uttar Pradesh at 12.7%.
  • Of all new cases at FMRI, Tobacco-related cancers constituted 23.4 % of all cancers amongst males and 8.8% of all cancers amongst females. In males, lung (31.2%) was the common site followed by urinary bladder (16.5%), mouth (16.5%), tongue (11.8%) and larynx (10.0%). In females, cancer of the lung (36.5) was the leading, followed by esophagus (18.8%), urinary bladder (15.3%), mouth (12.9%) and tongue (10.6%).
  • Paediatric cancers account for 5.8 % of the total cancer cases reported at FMRI during 2014. The total paediatric cancer load among boys and girls were 6.6% and 4.9 % respectively. The most common site of cancer, in boys between the ages of 0 to 14 years, is that of the nervous system
    followed by lymphoid leukaemia. While this amongst girls in the ages of 0 to 14, is leukaemia followed by cancer in the nervous system.
  • The disease affects about 11.5% young adults of all cancers seen and 57% population in their middle ages of all cancers seen. Geriatric cancers affect 25.7% of all cancers seen at the Centre.
  • Of the 617 international patients who came for taking treatment most were from Iraq (65.2%) followed by Nigeria (5.7%), Afghanistan (4.4%), Uzbekistan (4.4%), Kenya (3.1%), Congo (2.8%), Russia (2.3%), Kazakhstan (1.9%), Nepal (1.8%) and Yemen (1.8%) 

Dr Vinod Raina, Executive Director, FMRI said, “Non-communicable diseases account for 53 % of all deaths in India, out of which cancer 6% of the deaths. The purpose of a cancer registry program is to collect data as per age, gender, geographical distributions, type of cancer, site of cancer, grading and staging of cancer(to evaluate degree of invasion and metastasis), management, morbidity and mortality. Such a database is critical for yearly mapping of prevalence, future planning of resources, assessment of preventive measures and charting important disease trends.”

Dr Simmardeep Singh Gill, Zonal Director, FMRI said, “The Department of Oncology at FMRI has a very advanced and comprehensive cancer care programme with a trans-disciplinary and multimodality approach in the field of adult and paediatric oncology. The FMRI Cancer Registry collects data on all new cases of cancer attending different out-patient departments of FMRI. It will enable us as well as other stakeholders in devising strategies to combat cancer on a large scale”.

The main sources of information of a hospital-based registry include information from treatment facilities, such as radiation oncology, medical oncology & surgical oncology clinics, information from diagnostic services, radiology departments, imaging clinics and information from medical records. Information collected is active (registry personal visit, direct patient data), passive (information derived from proforma filled in by the healthcare staff) as well as automated (computerized registry data). A unique registration number (cancer registry number) is assigned by the registry to each patient. If a patient has more than one type of primary tumour, a number is given to each tumour. FMRI-HBCR is a paperless registry. Collected data were analysed using the software Statistical Package for Social Sciences (SPSS) version 16.0. Descriptive statistical measures such as percentage, mean and standard deviation were applied. Inferential statistics tests such as Z-test and Chi- square test are applied to identify important relationship between variables.

For detailed Press Release - Click here (English)Click here (Hindi)

For Key findings of Cancer registry data - Click here

PrintCopy TextGo Back


Feedback Form